Evans LA et al. |
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model. |
1996 |
Pharm. Res. |
pmid:8899856
|
Segreti J et al. |
In vitro activity of macrolides against intracellular Legionella pneumophila. |
1996 |
Diagn. Microbiol. Infect. Dis. |
pmid:8902407
|
Gastearena I et al. |
Determination of the alpha1-acid glycoprotein binding of azithromycin in vitro by equilibrium dialysis. |
1995 |
J Chemother |
pmid:8904095
|
Domingo S et al. |
Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis. |
1995 |
J Chemother |
pmid:8904096
|
Wendel TD |
1-day azithromycin was as effective as 7-day doxycycline for nongonococcal urethritis syndrome in men. |
1996 Nov-Dec |
ACP J. Club |
pmid:8912627
|
Luke DR et al. |
Safety, toleration, and pharmacokinetics of intravenous azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913468
|
Olsen KM et al. |
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913469
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
O'Doherty B |
Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8922571
|
Griffith DE et al. |
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8922790
|
Chulig I |
[Pharmacokinetic profile of azithromycin. Role in the treatment of genital Chlamydia infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929112
|
Kuznetsova SM |
["Sumamed in the treatment of urogenital infections"]. |
1996 |
Antibiot. Khimioter. |
pmid:8929115
|
Skripkin IuK et al. |
[The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. |
1996 |
Antibiot. Khimioter. |
pmid:8929120
|
Vasil'ev MM and Gazarian IIu |
[Clinico-laboratory evaluation of the effectiveness of azithromycin in the treatment of patients with Chlamydia and mixed Chlamydia-gonorrhea infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929122
|
Meloni G and Meloni T |
Azithromycin vs. doxycycline for Mediterranean spotted fever. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8933556
|
Jackson MA et al. |
Breakthrough sepsis in macrolide-resistant pneumococcal infection. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8933560
|
Keysary A et al. |
The in-vitro anti-rickettsial activity of macrolides. |
1996 |
J. Antimicrob. Chemother. |
pmid:8937968
|
Mein J et al. |
Donovanosis: sequelae of severe disease and successful azithromycin treatment. |
1996 |
Int J STD AIDS |
pmid:8940677
|
Hoque S et al. |
Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8941608
|
Wiselka MJ et al. |
Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. |
1996 |
J. Infect. |
pmid:8945715
|
Tansey MJ and Moe JB |
Severe neutropenia and prophylactic doses of rifabutin. |
1996 |
Lancet |
pmid:8950911
|
Sefton AM et al. |
Azithromycin in the treatment of periodontal disease. Effect on microbial flora. |
1996 |
J. Clin. Periodontol. |
pmid:8951627
|
Griffith DE et al. |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. |
1996 |
Clin. Infect. Dis. |
pmid:8953085
|
Brihmer C et al. |
Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women. |
1996 |
Scand. J. Infect. Dis. |
pmid:8953672
|
Van Bambeke F et al. |
Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. |
1996 |
Eur. J. Pharmacol. |
pmid:8957238
|
Montenez JP et al. |
Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies. |
1996 |
Eur. J. Pharmacol. |
pmid:8957239
|
Ripa S et al. |
A linear model for the pharmacokinetics of azithromycin in healthy volunteers. |
1996 Nov-Dec |
Chemotherapy |
pmid:8957574
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Cammarota G et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971300
|
Pilotto A et al. |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971305
|
Andenaes K et al. |
Preoperative bacterial colonization and its influence on postoperative wound infections in plastic surgery. |
1996 |
J. Hosp. Infect. |
pmid:8971618
|
Pozniak A and Nelson MR |
Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis. |
1996 |
Genitourin Med |
pmid:8976832
|
Schwartz RA et al. |
Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. |
1996 |
Br. J. Dermatol. |
pmid:8977724
|
Vranes J |
Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains. |
1996 May-Jun |
Chemotherapy |
pmid:8983884
|
Ichimiya T et al. |
The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. |
1996 May-Jun |
Chemotherapy |
pmid:8983885
|
Galova K et al. |
Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. |
1996 May-Jun |
Chemotherapy |
pmid:8983893
|
Akita H et al. |
[Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field]. |
1996 |
Jpn J Antibiot |
pmid:8986553
|
Nishimura T et al. |
[Clinical evaluation of azithromycin in pediatric infections]. |
1996 |
Jpn J Antibiot |
pmid:8986554
|
Haruta T and Kobayashi Y |
[Therapeutic efficacy of azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8986555
|
Kuroda Y and Ito M |
[Therapy with azithromycin in pediatric infections]. |
1996 |
Jpn J Antibiot |
pmid:8986556
|
Okamoto T and Sekiguchi T |
[Clinical studies on azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8986557
|
Toyonaga Y et al. |
[Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients]. |
1996 |
Jpn J Antibiot |
pmid:8988410
|
Okumura A and Kuno K |
[Pharmacokinetic and clinical evaluation of azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8988411
|
Kobayashi Y et al. |
[Clinical study of a macrolide antibiotic, azithromycin, in pediatric patients]. |
1996 |
Jpn J Antibiot |
pmid:8988412
|
Furukawa S and Okada T |
[A clinical evaluation of azithromycin in the treatment of pediatric infection]. |
1996 |
Jpn J Antibiot |
pmid:8988413
|
Okada T et al. |
[Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field]. |
1996 |
Jpn J Antibiot |
pmid:8988414
|
Ishida Y et al. |
[Pharmacokinetic and clinical evaluation of azithromycin in pediatric infections]. |
1996 |
Jpn J Antibiot |
pmid:8988415
|
Ohtsuka Y et al. |
[Pharmacokinetic and clinical studies on azithromycin in children]. |
1996 |
Jpn J Antibiot |
pmid:8988416
|
Tseng AL et al. |
Azithromycin-related ototoxicity in patients infected with human immunodeficiency virus. |
1997 |
Clin. Infect. Dis. |
pmid:8994766
|